启明创投

新闻

相关新闻

  1. The developer of drugs for advanced or recurrent cancers has already conducted nine financing rounds, but will not start generating commercial revenue before 2026, as all its products are still in the trial stages.
    药捷安康曾9轮融资 事隔三年再冲港交所
  2. 欠收入亏损扩 泽辉生物求上市注资
掌握中概股最新动态，订阅我们的新闻邮件

关注我们

Facebook Twitter Linkedin Weixin Weibo Youtube

免费订阅新闻邮件

订阅邮件

在以下平台浏览我们的新闻

factiva